S. Kalstad

1.9k total citations
15 papers, 699 citations indexed

About

S. Kalstad is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, S. Kalstad has authored 15 papers receiving a total of 699 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Rheumatology, 6 papers in Immunology and 5 papers in Hematology. Recurrent topics in S. Kalstad's work include Rheumatoid Arthritis Research and Therapies (13 papers), Spondyloarthritis Studies and Treatments (9 papers) and Systemic Lupus Erythematosus Research (5 papers). S. Kalstad is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (13 papers), Spondyloarthritis Studies and Treatments (9 papers) and Systemic Lupus Erythematosus Research (5 papers). S. Kalstad collaborates with scholars based in Norway, Netherlands and Sweden. S. Kalstad's co-authors include Tore K Kvien, Elisabeth Lie, K. M. Fagerli, Erik Rødevand, K. Mikkelsen, Ada Wierød, Åse Stavland Lexberg, Marte Schrumpf Heiberg, Désirée van der Heijde and E Rødevand and has published in prestigious journals such as Annals of the Rheumatic Diseases, Lara D. Veeken and Arthritis & Rheumatology.

In The Last Decade

S. Kalstad

13 papers receiving 687 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Kalstad Norway 11 596 289 281 56 53 15 699
T. Uhlig Norway 11 536 0.9× 151 0.5× 218 0.8× 63 1.1× 33 0.6× 18 707
K. M. Fagerli Norway 15 768 1.3× 401 1.4× 302 1.1× 83 1.5× 12 0.2× 41 866
Ada Wierød Norway 8 335 0.6× 108 0.4× 148 0.5× 44 0.8× 38 0.7× 13 404
Laura Diekman United States 9 585 1.0× 366 1.3× 220 0.8× 101 1.8× 22 0.4× 18 766
J. M. W. Hazes Netherlands 10 375 0.6× 144 0.5× 108 0.4× 72 1.3× 45 0.8× 20 574
Frode Krøll Norway 9 258 0.4× 73 0.3× 123 0.4× 38 0.7× 24 0.5× 15 384
Charles Masson France 14 289 0.5× 231 0.8× 268 1.0× 77 1.4× 33 0.6× 24 754
Daniel Seoane‐Mato Spain 13 382 0.6× 175 0.6× 123 0.4× 33 0.6× 9 0.2× 41 557
Sally Cox Australia 13 281 0.5× 101 0.3× 65 0.2× 128 2.3× 56 1.1× 18 546
K Sokoll United Kingdom 7 461 0.8× 304 1.1× 187 0.7× 51 0.9× 14 0.3× 11 536

Countries citing papers authored by S. Kalstad

Since Specialization
Citations

This map shows the geographic impact of S. Kalstad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Kalstad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Kalstad more than expected).

Fields of papers citing papers by S. Kalstad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Kalstad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Kalstad. The network helps show where S. Kalstad may publish in the future.

Co-authorship network of co-authors of S. Kalstad

This figure shows the co-authorship network connecting the top 25 collaborators of S. Kalstad. A scholar is included among the top collaborators of S. Kalstad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Kalstad. S. Kalstad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Michelsen, Brigitte, Eirik Klami Kristianslund, Joseph Sexton, et al.. (2017). Do depression and anxiety reduce the likelihood of remission in rheumatoid arthritis and psoriatic arthritis? Data from the prospective multicentre NOR-DMARD study. Annals of the Rheumatic Diseases. 76(11). 1906–1910. 170 indexed citations
2.
3.
Uhlig, Till, Elisabeth Lie, Åse Stavland Lexberg, et al.. (2016). Achievement of Remission and Low Disease Activity Definitions in Patients with Rheumatoid Arthritis in Clinical Practice: Results from the NOR-DMARD Study. The Journal of Rheumatology. 43(4). 716–723. 18 indexed citations
4.
5.
Fagerli, K. M., D. van der Heijde, Marte Schrumpf Heiberg, et al.. (2014). Is there a role for sulphasalazine in axial spondyloarthritis in the era of TNF inhibition? Data from the NOR-DMARD longitudinal observational study. Lara D. Veeken. 53(6). 1087–1094. 10 indexed citations
6.
Wallenius, Marianne, Elisabeth Lie, Anne Kjersti Daltveit, et al.. (2014). Brief Report: No Excess Risks in Offspring With Paternal Preconception Exposure to Disease‐Modifying Antirheumatic Drugs. Arthritis & Rheumatology. 67(1). 296–301. 35 indexed citations
7.
Fagerli, K. M., Elisabeth Lie, Désirée van der Heijde, et al.. (2013). Switching between TNF inhibitors in psoriatic arthritis: data from the NOR-DMARD study. Annals of the Rheumatic Diseases. 72(11). 1840–1844. 98 indexed citations
8.
Fagerli, K. M., Elisabeth Lie, Désirée van der Heijde, et al.. (2013). The role of methotrexate co-medication in TNF-inhibitor treatment in patients with psoriatic arthritis: results from 440 patients included in the NOR-DMARD study. Annals of the Rheumatic Diseases. 73(1). 132–137. 131 indexed citations
9.
Aga, Anna‐Birgitte, Elisabeth Lie, Till Uhlig, et al.. (2013). Time trends in disease activity, response and remission rates in rheumatoid arthritis during the past decade: results from the NOR-DMARD study 2000–2010. Annals of the Rheumatic Diseases. 74(2). 381–388. 127 indexed citations
10.
Fagerli, K. M., Désirée van der Heijde, Marte Schrumpf Heiberg, et al.. (2013). FRI0411 Response and drug survival of sulfasalazine in an observational study (nor-dmard) of dmard-naïve patients with axial spondyloarthritis (SPA). Annals of the Rheumatic Diseases. 72. A512–A513. 1 indexed citations
11.
Fagerli, K. M., E. Lie, Désirée van der Heijde, et al.. (2012). Selecting patients with ankylosing spondylitis for TNF inhibitor therapy: comparison of ASDAS and BASDAI eligibility criteria. Lara D. Veeken. 51(8). 1479–1483. 31 indexed citations
12.
13.
Fagerli, K. M., E. Lie, Désirée van der Heijde, et al.. (2011). Predictors of ASDAS Major Improvement in Patients with Ankylosing Spondylitis Receiving Their First TNF Inhibitor. Results From a Longitudinal Observational Study. Data Archiving and Networked Services (DANS). 63(10). 4 indexed citations
14.
Lie, E., D. van der Heijde, Till Uhlig, et al.. (2011). Treatment strategies in patients with rheumatoid arthritis for whom methotrexate monotherapy has failed: data from the NOR-DMARD register. Annals of the Rheumatic Diseases. 70(12). 2103–2110. 19 indexed citations
15.
Lie, E., Till Uhlig, D. van der Heijde, et al.. (2011). Effectiveness of sulfasalazine and methotrexate in 1102 DMARD-naive patients with early RA. Lara D. Veeken. 51(4). 670–678. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by T. Uhlig Breakdown of academic impact, for papers by K. M. Fagerli Breakdown of academic impact, for papers by Ada Wierød Breakdown of academic impact, for papers by Laura Diekman Breakdown of academic impact, for papers by J. M. W. Hazes Breakdown of academic impact, for papers by Frode Krøll Breakdown of academic impact, for papers by Charles Masson Breakdown of academic impact, for papers by Daniel Seoane‐Mato Breakdown of academic impact, for papers by Sally Cox Breakdown of academic impact, for papers by K Sokoll
Rankless by CCL
2026